Company intelligence / Profile preview

Re:course AI

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Re:course AI has developed an advanced conversational AI "flight simulator" for healthcare professionals, using digital human avatars to provide realistic patient interactions and automatic feedback. Early evaluations show significant improvements in clinician performance during simulated patient encounters, including rare cancer diagnosis and mental health assessments[5].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

UCB (pharma partnership to transform dermatology education using custom avatars for hidradenitis suppurativa)

Beyond the preview

Go deeper on Re:course AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Re:course AI.

Explore the full profile